Results 1 to 10 of about 142,249 (285)

The CD28-Transmembrane Domain Mediates Chimeric Antigen Receptor Heterodimerization With CD28 [PDF]

open access: yesFrontiers in Immunology, 2021
Anti-CD19 chimeric antigen receptor (CD19-CAR)-engineered T cells are approved therapeutics for malignancies. The impact of the hinge domain (HD) and the transmembrane domain (TMD) between the extracellular antigen-targeting CARs and the intracellular ...
Yannick D. Muller   +28 more
doaj   +7 more sources

Association of the genetic polymorphisms in inhibiting and activating molecules of immune system with rheumatoid arthritis: A systematic review and meta-analysis

open access: yesJournal of Research in Medical Sciences, 2021
Several studies have demonstrated that the genetic polymorphisms in the genes encoding immune regulatory molecules, namely cytotoxic T-lymphocyte-associated protein 4 (CTLA4) and CD28, play a fundamental role in susceptibility to rheumatoid arthritis (RA)
Mohammad Javad Mousavi   +6 more
doaj   +1 more source

Mice transgenic for human CTLA4-CD28 fusion gene show proliferation and transformation of ATLL-like and AITL-like T cells

open access: yesOncoImmunology, 2022
CTLA4-CD28 gene fusion has been reported to occur in diverse types of T cell lymphoma. The fusion event is expected to convert inhibitory signals to activating signals and promote proliferation and potentially transformation of T cells.
Gyu Jin Lee   +5 more
doaj   +1 more source

Detection of senescent CD8+ T-lymphocyte in newly diagnosed and relapsed/refractory multiple myeloma using CD28 and CD57

open access: yesIraqi Journal of Hematology, 2023
BACKGROUND: Multiple myeloma is a clonal B-cell malignancy characterized by proliferation of plasma cells that secrete a complete and/or partial monoclonal immunoglobulin protein.
Zahraa Mahdi Sareeh   +2 more
doaj   +1 more source

SNX9-induced membrane tubulation regulates CD28 cluster stability and signalling

open access: yeseLife, 2022
T cell activation requires engagement of a cognate antigen by the T cell receptor (TCR) and the co-stimulatory signal of CD28. Both TCR and CD28 aggregate into clusters at the plasma membrane of activated T cells.
Manuela Ecker   +9 more
doaj   +1 more source

IL-7 Promotes the Expansion of Circulating CD28- Cytotoxic T Lymphocytes in Patients With IgG4-Related Disease via the JAK Signaling

open access: yesFrontiers in Immunology, 2022
ObjectivesThis study aimed to elucidate the changes and associated mechanisms of circulating CD28- cytotoxic T lymphocytes (CTLs) in patients with IgG4-related disease (IgG4-RD).MethodsFifty IgG4-RD patients and 15 healthy controls (HCs) were recruited ...
Chang-sheng Xia   +5 more
doaj   +1 more source

Inducible deletion of CD28 prior to secondary nippostrongylus brasiliensis infection impairs worm expulsion and recall of protective memory CD4⁺ T cell responses. [PDF]

open access: yesPLoS Pathogens, 2014
IL-13 driven Th2 immunity is indispensable for host protection against infection with the gastrointestinal nematode Nippostronglus brasiliensis. Disruption of CD28 mediated costimulation impairs development of adequate Th2 immunity, showing an importance
Hlumani Ndlovu   +6 more
doaj   +1 more source

Serum antibodies against CD28-- a new potential marker of dismal prognosis in melanoma patients. [PDF]

open access: yesPLoS ONE, 2013
BACKGROUND: Autoantibodies against CD28 have been found in patients with autoimmune and atopic diseases. These antibodies may act as superagonists and activate T cells but may also be antagonistic or induce immunosuppressive effects by activating ...
Rebecca Körner   +12 more
doaj   +1 more source

Increased Neopterin Concentration in Older Age Coincides with Decline of CD28+CD45RA+ T-cells

open access: yesPteridines, 2004
Neopterin is produced from human monocyte-derived macrophages and dendritic cells upon Stimulation with interferon-y, and increased neopterin concentrations thus indicate cell-mediated immune activation.
Murr Christian   +7 more
doaj   +1 more source

BELATACEPT IN RENAL TRANSPLANTATION

open access: yesВестник трансплантологии и искусственных органов, 2013
Belatacept is a novel immunosuppressive agent that inhibits T-cell activation by blocking CD28 signaling pa- thway. It was developed based on abatacept (CTLA-4Ig), the first recombinant immunoglobulin fusion protein which contains extracellular part of ...
A. I. Sushkov, Y. G. Moysyuk
doaj   +1 more source

Home - About - Disclaimer - Privacy